why choose us

First received: August 06, 2024

Clinical Trial: A Study Designed to Evaluate Tear Production

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dry Eye Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 3b Open-Label Study Designed to Evaluate Tear Production Stimulated by 0.003% AR-15512

Brief Summary: The purpose of this study is to evaluate tear production following acute administration of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) in subjects with dry eye disease (DED).

Read more